Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease pulmonary hypertension
Phenotype C0011644|scleroderma
Sentences 10
PubMedID- 20335527 The presence of the hla-b35 allele has emerged as an important risk factor for the development of isolated pulmonary hypertension in patients with scleroderma, however the mechanisms underlying this association have not been fully elucidated.
PubMedID- 21548946 Furthermore, it has been shown that gdf-15 serum levels are increased in scleroderma patients with pulmonary hypertension and gdf-15 protein was predominantly located in monocytes infiltrating the lung tissue [18].
PubMedID- 20973920 Our goal is to identify differentially expressed genes in peripheral blood mononuclear cells in scleroderma patients with and without pulmonary hypertension as biomarkers of disease.
PubMedID- 20862337 The prevalence of pulmonary hypertension associated with scleroderma ranged from 4.9% to 38% as written in the accp guidelines.
PubMedID- 23780636 Clinical and laboratory features of scleroderma patients with pulmonary hypertension.
PubMedID- 23042670 We sought to assess the construct validity and responsiveness of the ucsd sobq in systemic sclerosis (ssc; scleroderma) patients with incident pulmonary hypertension (ph) and those at high risk of developing ph.
PubMedID- 23130095 [2] subsequently, a second epoprostenol trial for patients with pulmonary hypertension associated with scleroderma resulted in fda approval for that condition.
PubMedID- 22836630 The present study was aimed at testing the prevalence of anti-endothelial cell antibodies (aeca) in systemic scleroderma (ssc) patients with and without pulmonary hypertension (ph) and in relation to the presence of pulmonary fibrosis.
PubMedID- 21597395 Objective: to detect coronary artery disease in asymptomatic patients with systemic lupus erythematosus and scleroderma associated with pulmonary hypertension, and to determine whether it is focal or diffuse ischemia.
PubMedID- 22549387 Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension.

Page: 1